Portfolio company
Vitricell
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops cryopreservation technology for researchers and clinics to preserve fragile cells and embryos using aseptic vitrification methods.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Cradle Health
This company develops reversible cryopreservation technology for research institutions and medical facilities to preserve and reanimate biological tissues and organs.
Vitra Bio
This biotechnology company develops in vitro fertilization technology and cell-based therapies to induce oogenesis outside the ovary for patients struggling with infertility.
Vitra Labs
The company develops a stem cell platform to produce eggs for patients undergoing fertility treatments without the use of hormones or donor tissue.
Vitroscope
The company develops automated perfusion platforms for cell and tissue research, providing microenvironment control systems to researchers and pharmaceutical laboratories.
X-Therma
This company develops non-toxic biopreservation solutions and transport devices for healthcare and research institutions to store and transport cells, tissues and organs.
VERITACELL
This company produces surgical kits for point-of-care skin cell isolation and regeneration to help surgeons and hospitals treat patient wounds and scarring.
Cryoveritas
Cryoveritas develops visual time-temperature indicators to monitor the integrity of biological samples and vaccines for research labs, biobanks, and logistics providers.
CryoLogyx
CryoLogyx provides cryopreserved, assay-ready cell lines for researchers in the drug discovery, diagnostics and biotechnology sectors.
